GU CONNECT has summarised the highlights of the recent ASCO GU 2018 meeting for you.


Renal Cell Carcinoma by Associate Professor Brian Costello, Mayo Clinic, USA

 

Brian A. Costello, M.D., M.S. is a Consultant in the Division of Medical Oncology at Mayo Clinic Rochester and is an Associate Professor of Oncology and Urology. He received his medical degree from the Medical College of Wisconsin and completed his internal medicine residency at the University of New Mexico School of Medicine. He then completed his medical oncology fellowship at Mayo Clinic. Dr Costello was subsequently a Mayo Clinic Scholar during which time he focused on early phase clinical trials and genitourinary malignancies. Dr Costello is currently the Chair of the Genitourinary Tumor Group of the Division of Medical Oncology at Mayo Clinic. He serves as a member of the NCCN Kidney Cancer Panel, the National Cancer Institute’s Renal Task Force, as well as the GU Cancers Core Committee of the Alliance for Clinical Trials in Oncology. He also previously served on the NCI Prostate Task Force from 2013 to 2016. He is actively involved in clinical and translational research and has a busy practice caring for patients with genitourinary cancers. Dr Costello is actively involved in early drug development, especially in genitourinary malignancies. He is the Lead Investigator of the NCI-sponsored Mayo Phase II Program and is a member of the NCI’s Investigational Drug Steering Committee.

Programme summary
  • clock Duration 5 MIN
  • clock Language(s) flag
Watch the video now
Other episodes in this series
A CONNECT Update from ASCO GU 2018

A CONNECT Update from ASCO GU 2018

Episode 2 Current Episode
Update from ASCO GU 2018

Update from ASCO GU 2018

Episode 4: Urothelial Carcinoma
Share this programme
This educational programme is supported by an Independent Educational Grant from Bayer
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
GU CONNECT

GU CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Bayer and Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

video Video
Oncology 
The evolving role of liquid biopsy in HR+/HER2- metastatic breast cancer

Exploring the impact of liquid biopsy in advanced breast cancer

Experts
Prof. Frédérique Penault-Llorca, Dr Aditya Bardia
Endorsed by
ISLB
  • download Downloadable
    Resources
  • clock 6 MIN
  • calendar Jan 2025

Educational programme supported by an Independent Educational Grant from Thermo Fisher Scientific.
animated-video Animated Video
Oncology Obstetrics and Gynecology 
Current treatment options in advanced/recurrent endometrial cancer

Exploring the impact of molecular subtypes 

Experts
Prof. Christian Marth
  • download Downloadable
    Resources
  • clock 7 MIN
  • calendar Jan 2025

Educational programme supported by an Independent Educational Grant from Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of or speakers involved in this programme.
podcast Podcast

Episode

3

of 3

episode
Oncology 
HCC podcast series part 3: Intermediate HCC – treatment options and strategies

Expert insights on systemic, loco-regional, and multimodal therapies

Experts
Dr Maria Reig, Assoc. Prof. Emil I Cohen, Oncology Brothers (Moderators)
Endorsed by
DiCE Blue Faery plus Global Liver Institute
ELPA
  • download Downloadable
    Resources
  • clock 20 MIN
  • calendar Jan 2025

Educational programme supported by an Independent Educational Grant from Bayer.
video Video
Oncology 
Recent advances in precision oncology and future implications

Two emerging and two established targets

Experts
Prof. David Hong
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Bayer.
publication Publication
Oncology 
Survey on the evolving role of the oncology nurse in the USA

Announcing the publication of survey results 

Experts
Nina Grenon, Natasha Pinheiro, Karen Waldrop, Brittni Prosdocimo
  • download Downloadable
    Resources
  • clock 10 MIN
  • calendar Dec 2024

Educational programme supported by an Independent Educational Grant from Bayer.
video Video
Oncology 
Elacestrant in ER+/HER2- metastatic breast cancer

An expert overview of the EMERALD subgroup analysis

Experts
Dr Virginia Kaklamani
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Dec 2024

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.